Assessing the Influence of Strategic Orientations on Sustained Competitive Advantage: A Study of the Kenyan Pharmaceutical Industry

Abstract

The pharmaceutical industry in Kenya operates within an increasingly competitive and regulated environment shaped by market fragmentation, supply chain constraints, rising healthcare demands, and performance pressures. Sustained competitive advantage has consequently become a strategic imperative for firms seeking long term survival and growth. Despite wide recognition of strategic orientation as a driver of organizational success, limited empirical evidence exists on the combined influence of product, market, alliance, and entrepreneurial orientations on sustained competitive advantage in the Kenyan pharmaceutical sector. This study examined this relationship using a post positivist philosophy and an explanatory research design. Data were collected from functional managers and senior executives at pharmaceutical firms operating in Kenya using a structured questionnaire, yielding 343 valid responses. Pearson correlation, multiple regression, and analysis of variance were employed for analysis. Findings revealed that all four strategic orientation dimensions were positively associated with sustained competitive advantage. Product orientation showed the strongest correlation (r = 0.272, p < 0.001), followed by alliance orientation (r = 0.268, p < 0.001), market orientation (r = 0.230, p < 0.001), and entrepreneurial orientation (r = 0.194, p < 0.001). The regression model was statistically significant (F = 20.219, p < 0.001) and explained 19.3% of the variance in sustained competitive advantage (R² = 0.193). Product orientation was the strongest predictor (β = 0.392, p < 0.001), followed by alliance orientation (β = 0.344, p < 0.001) and market orientation (β = 0.341, p < 0.001), while entrepreneurial orientation showed a positive but marginally non-significant effect (β = 0.170, p = 0.053). The study concludes that strategic orientation significantly determines sustained competitive advantage among Kenyan pharmaceutical firms. Strengthening product development, market responsiveness, and strategic partnerships is recommended to enhance long term competitiveness. These findings offer valuable insights for managers, policymakers, and industry stakeholders.